Literature DB >> 30858639

Exercise as a Treatment for Schizophrenia: A Review.

Steven J Girdler1, Jamie E Confino1, Mary E Woesner1.   

Abstract

Schizophrenia is a mental disorder that is characterized by progressive cognitive impairment in areas of attention, working memory, and executive functioning. Although no clear etiology of schizophrenia has been discovered, many factors have been identified that contribute to the development of the disease, such as neurotransmitter alterations, decreased synaptic plasticity, and diminished hippocampal volume. Historically, antipsychotic medications have targeted biochemical alterations in the brains of patients with schizophrenia but have been ineffective in alleviating cognitive and hippocampal deficits. Other modalities, such as exercise therapy, have been proposed as adjuvant or primary therapy options. Exercise therapy has been shown to improve positive and negative symptoms, quality of life, cognition, and hippocampal plasticity, and to increase hippocampal volume in the brains of patients with schizophrenia. This article will briefly review the clinical signs, symptoms and proposed etiologies of schizophrenia, and describe the current understanding of exercise programs as an effective treatment in patients with the disease.

Entities:  

Keywords:  exercise; neurodevelopment; schizophrenia; synaptic plasticity; treatment

Mesh:

Year:  2019        PMID: 30858639      PMCID: PMC6386427     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  40 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

2.  Neural stem cell proliferation is decreased in schizophrenia, but not in depression.

Authors:  A Reif; S Fritzen; M Finger; A Strobel; M Lauer; A Schmitt; K-P Lesch
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

Review 3.  Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.

Authors:  M J Green; S L Matheson; A Shepherd; C S Weickert; V J Carr
Journal:  Mol Psychiatry       Date:  2010-08-24       Impact factor: 15.992

4.  White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs.

Authors:  Paul Klauser; Simon T Baker; Vanessa L Cropley; Chad Bousman; Alex Fornito; Luca Cocchi; Janice M Fullerton; Paul Rasser; Ulrich Schall; Frans Henskens; Patricia T Michie; Carmel Loughland; Stanley V Catts; Bryan Mowry; Thomas W Weickert; Cynthia Shannon Weickert; Vaughan Carr; Rhoshel Lenroot; Christos Pantelis; Andrew Zalesky
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

5.  The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

Authors:  Jonathan M Meyer; Henry A Nasrallah; Joseph P McEvoy; Donald C Goff; Sonia M Davis; Miranda Chakos; Jayendra K Patel; Richard S E Keefe; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2005-08-24       Impact factor: 4.939

6.  The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial.

Authors:  David Kimhy; Julia Vakhrusheva; Matthew N Bartels; Hilary F Armstrong; Jacob S Ballon; Samira Khan; Rachel W Chang; Marie C Hansen; Lindsey Ayanruoh; Amanda Lister; Eero Castrén; Edward E Smith; Richard P Sloan
Journal:  Schizophr Bull       Date:  2015-03-23       Impact factor: 9.306

Review 7.  Neurobiological effects of exercise on major depressive disorder: A systematic review.

Authors:  Felipe Barreto Schuch; Andrea Camaz Deslandes; Brendon Stubbs; Natan Pereira Gosmann; Cristiano Tschiedel Belem da Silva; Marcelo Pio de Almeida Fleck
Journal:  Neurosci Biobehav Rev       Date:  2015-12-02       Impact factor: 8.989

8.  Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition.

Authors:  Fernando Gomez-Pinilla; Shoshanna Vaynman; Zhe Ying
Journal:  Eur J Neurosci       Date:  2008-12       Impact factor: 3.386

Review 9.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

Review 10.  Pharmacological cognitive enhancement in schizophrenia.

Authors:  Philip D Harvey
Journal:  Neuropsychol Rev       Date:  2009-06-09       Impact factor: 7.444

View more
  9 in total

Review 1.  Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review.

Authors:  Hannah W Haddad; Elena Boardman; Brooke Williams; Rama Mouhaffel; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-04-25

2.  Outcomes of Physiotherapy on Activities of Daily Living and Discharge to the Community in Psychiatric Long-term Care Ward Patients.

Authors:  Munetsugu Kota; Sae Uezono; Yusuke Ishibashi; Shouichi Kuramochi; Sousuke Kitakaze; Seiji Kaganoi
Journal:  Phys Ther Res       Date:  2022-05-13

3.  Schizophrenia Outside the Brain.

Authors:  Aline Gazzola Fragnani Valença; Bradley Joseph Smith
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Effects of the Health-Awareness-Strengthening Lifestyle Program in a Randomized Trial of Young Adults with an At-Risk Mental State.

Authors:  Ching-Lun Tsai; Ya-Wen Lin; Hsing-Chi Hsu; Mei-Ling Lou; Hsien-Yuan Lane; Cheng-Hao Tu; Wei-Fen Ma
Journal:  Int J Environ Res Public Health       Date:  2021-02-18       Impact factor: 3.390

5.  Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily nursing: A protocol for systematic review and meta-analysis.

Authors:  Chunmian Chen; Yafang Yang; Xinwu Ye; Yulian Jin; Ziyao Cai; Jie Zheng
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

6.  Effects of iTBS-rTMS on the Behavioral Phenotype of a Rat Model of Maternal Immune Activation.

Authors:  Nadine Rittweger; Tanja Ishorst; Gleb Barmashenko; Verena Aliane; Christine Winter; Klaus Funke
Journal:  Front Behav Neurosci       Date:  2021-04-21       Impact factor: 3.558

7.  Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia.

Authors:  Xiao Zhong; Qin Ao; Fei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-13       Impact factor: 2.629

8.  Are Executive Functions Deficits in Early-Onset Chronic Schizophrenia More Severe than in Adult-Onset Chronic Schizophrenia?

Authors:  Beata Hintze; Magdalena Rowicka; Anna Barczak
Journal:  Clin Neuropsychiatry       Date:  2022-02

Review 9.  The effects and mechanism of environmental enrichment on MK-801 induced cognitive impairment in rodents with schizophrenia.

Authors:  Jinwei Xu; Yaohao Li; Biqing Tian; Haiying Liu; Shengxi Wu; Wenting Wang
Journal:  Front Cell Neurosci       Date:  2022-09-29       Impact factor: 6.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.